Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 58, Issue 7, 2008, Pages 1892-1899

  Van Bavel, Casandra C ^a   Fenton, Kristin A ^b   Rekvig, Ole P ^b   Van Der Vlag, Johan ^a   Berden, Jo H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CROSS REACTING ANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA; HISTONE; KIDNEY ANTIBODY; LAMININ;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; CHROMATIN; DNA STRUCTURE; GLOMERULAR STRUCTURE; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MOLECULAR MIMICRY; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTINUCLEAR; DNA; HUMANS; KIDNEY GLOMERULUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS;

EID: 47249092794     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23626     Document Type: Review

References (54)

1. Tan EM. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol 1982;33:167-240.
2. Pisetsky DS. Anti-DNA and autoantibodies. Curr Opin Rheumatol 2000;12:364-8.
3. Dieker JW, van der Vlag J, Berden JH. Triggers for antichromatin autoantibody production in SLE. Lupus 2002;11: 856-64.
4. Bruns A, Blass S, Hausdorf G, Burmester GR, Hiepe F. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum 2000;43:2307-15.
5. Cervera R, Vinas O, Ramos-Casals M, Font J, Garcia-Carrasco M, Siso A, et al. Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann Rheum Dis 2003;62:431-4.
6. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997;389:251-60.
7. Burlingame RW, Cervera R. Anti-chromatin (anti-nucleosome) autoantibodies. Autoimmun Rev 2002;1:321-8.
8. Kalaaji M, Fenton K, Mortensen E, Olsen R, Sturfelt G, Alm P, et al. Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int 2007;71:664-72.
9. Kalaaji M, Mortensen E, Jorgensen L, Olsen R, Rekvig OP. Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells. Am J Pathol 2006;168:1779-92.
10. Kalaaji M, Sturfelt G, Mjelle JE, Nossent H, Rekvig OP. Critical comparative analyses of anti-α-actinin and glomerulus-bound antibodies in human and murine lupus nephritis. Arthritis Rheum 2006;54:914-26.
11. Eilat D. Cross-reactions of anti-DNA antibodies and the central dogma of lupus nephritis. Immunol Today 1985;6:123-7.
12. Budhai L, Oh K, Davidson A. An in vitro assay for detection of glomerular binding IgG autoantibodies in patients with systemic lupus erythematosus. J Clin Invest 1996;98:1585-93.
13. Raz E, Brezis M, Rosenmann E, Eilat D. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol 1989;142:3076-82.
14. Madaio MP, Carlson J, Cataldo J, Ucci A, Migliorini P, Pankewycz O. Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits. J Immunol 1987; 138:2883-9.
15. Vlahakos DV, Foster MH, Adams S, Katz M, Ucci AA, Barrett KJ, et al. Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int 1992;41:1690-700.
16. D'Andrea DM, Coupaye-Gerard B, Kleyman TR, Foster MH, Madaio MP. Lupus autoantibodies interact directly with distinct glomerular and vascular cell surface antigens. Kidney Int 1996;49: 1214-21.
17. Mostoslavsky G, Fischel R, Yachimovich N, Yarkoni Y, Rosenmann E, Monestier M, et al. Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur J Immunol 2001;31:1221-7.
18. Sabbaga J, Pankewycz OG, Lufft V, Schwartz RS, Madaio MP. Cross-reactivity distinguishes serum and nephritogenic anti-DNA antibodies in human lupus from their natural counterparts in normal serum. J Autoimmun 1990;3:215-35.
19. Koike T, Tomioka H, Kumagai A. Antibodies cross-reactive with DNA and cardiolipin in patients with systemic lupus erythematosus. Clin Exp Immunol 1982;50:298-302.
20. Lafer EM, Rauch J, Andrzejewski C Jr, Mudd D, Furie B, Schwartz RS, et al. Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med 1981;153:897-909.
21. Smeenk RJ, Lucassen WA, Swaak TJ. Is anticardiolipin activity a cross-reaction of anti-DNA or a separate entity? Arthritis Rheum 1987;30:607-17.
22. Pereira LF, Marco FM, Boimorto R, Caturla A, Bustos A, De la Concha EG, et al. Histones interact with anionic phospholipids with high avidity; its relevance for the binding of histone-antihistone immune complexes. Clin Exp Immunol 1994;97:175-80.
23. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990;336:177-8.
24. Dieker JW, Sun YJ, Jacobs CW, Putterman C, Monestier M, Muller S, et al. Mimotopes for lupus-derived anti-DNA and nucleosome-specific autoantibodies selected from random peptide phage display libraries: facts and follies. J Immunol Methods 2005;296:83-93.
25. Gaynor B, Putterman C, Valadon P, Spatz L, Scharff MD, Diamond B. Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc Natl Acad Sci U S A 1997;94:1955-60.
26. Shefner R, Kleiner G, Turken A, Papazian L, Diamond B. A novel class of anti-DNA antibodies identified in BALB/c mice. J Exp Med 1991;173:287-96.
27. Putterman C, Diamond B. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J Exp Med 1998;188: 29-38.
28. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001;7:1189-93.
29. Deocharan B, Qing X, Lichauco J, Putterman C. α-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J Immunol 2002;168:3072-8.
30. Ylanne J, Scheffzek K, Young P, Saraste M. Crystal structure of the α-actinin rod reveals an extensive torsional twist. Structure 2001;9:597-604.
31. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, et al. Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000;24: 251-6.
32. Mason LJ, Ravirajan CT, Rahman A, Putterman C, Isenberg DA. Is α-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis? Arthritis Rheum 2004;50:866-70.
33. Zhao Z, Weinstein E, Tuzova M, Davidson A, Mundel P, Marambio P, et al. Cross-reactivity of human lupus anti-DNA antibodies with α-actinin and nephritogenic potential. Arthritis Rheum 2005; 52:522-30.
34. Monestier M, Novick KE. Specificities and genetic characteristics of nucleosome-reactive antibodies from autoimmune mice. Mol Immunol 1996;33:89-99.
35. Faaber P, Rijke TP, van de Putte LB, Capel PJ, Berden JH. Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate: the major glycosaminoglycan in glomerular basement membranes. J Clin Invest 1986;77:1824-30.
36. Migliorini P, Pratesi F, Bongiorni F, Moscato S, Scavuzzo M, Bombardieri S. The targets of nephritogenic antibodies in systemic autoimmune disorders. Autoimmun Rev 2002;1:168-73.
37. Mosca M, Chimenti D, Pratesi F, Baldini C, Anzilotti C, Bombardieri S, et al. Prevalence and clinico-serological correlations of anti-α-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus. J Rheumatol 2006;33:695-7.
38. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33.
39. Termaat RM, Brinkman K, van Gompel F, van den Heuvel LP, Veerkamp JH, Smeenk RJ, et al. Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. J Autoimmun 1990;3:531-45.
40. Franek F, Dolnikova J. Nucleosomes occurring in protein-free hybridoma cell culture: evidence for programmed cell death. FEBS Lett 1991;284:285-7.
41. Subiza JL, Caturla A, Pascual-Salcedo D, Chamorro MJ, Gazapo E, Figueredo MA, et al. DNA-anti-DNA complexes account for part of the antihistone activity found in patients with systemic lupus erythematosus. Arthritis Rheum 1989;32:406-12.
42. Kramers C, Hylkema MN, van Bruggen MC, van de Lagemaat R, Dijkman HB, Assmann KJ, et al. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest 1994;94:568-77.
43. Van Bruggen MC, Walgreen B, Rijke TP, Corsius MJ, Assmann KJ, Smeenk RJ, et al. Heparin and heparinoids prevent the binding of immune complexes containing nucleosomal antigens to the GBM and delay nephritis in MRL/lpr mice. Kidney Int 1996;50:1555-64.
44. Van Bruggen MC, Walgreen B, Rijke TP, Tamboer W, Kramers K, Smeenk RJ, et al. Antigen specificity of anti-nuclear antibodies complexed to nucleosomes determines glomerular basement membrane binding in vivo. Eur J Immunol 1997;27:1564-9.
45. Rops AL, van den Hoven MJ, Bakker MA, Lensen JF, Wijnhoven TJ, van den Heuvel LP, et al. Expression of glomerular heparan sulphate domains in murine and human lupus nephritis [published erratum appears in Nephrol Dial Transplant 2007;22:2416]. Nephrol Dial Transplant 2007;22:1891-902.
46. Van Bruggen MC, Kramers C, Walgreen B, Elema JD, Kallenberg CG, van den Born J, et al. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis. Nephrol Dial Transplant 1997;12:57-66.
47. Grootscholten C, van Bruggen MC, van der Pijl JW, de Jong EM, Ligtenberg G, Derksen RH, et al, for the Dutch Working Party on SystemicLupus Erythematosus. Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis. Arthritis Rheum 2003;48:1355-62.
48. Lefkowith JB, Gilkeson GS. Nephritogenic autoantibodies in lupus: current concepts and continuing controversies [review]. Arthritis Rheum 1996;39:894-903.
49. Mjelle JE, Rekvig OP, Fenton KA. Nucleosomes possess a high affinity for glomerular laminin and collagen IV and bind nephritogenic antibodies in murine lupus-like nephritis. Ann Rheum Dis 2007;66:1661-8.
50. Griffiths G, Burke B, Lucocq J. Fine structure immunocytochemistry. Berlin: Springer-Verlag; 1993.
51. Rekvig OP, Moens U, Sundsfjord A, Bredholt G, Osei A, Haaheim H, et al. Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen: a molecular basis for induction of antibodies to DNA and eukaryotic transcription factors. J Clin Invest 1997;99:2045-54.
52. Zhang W, Reichlin M. A peptide DNA surrogate that binds and inhibits anti-dsDNA antibodies. Clin Immunol 2005;117:214-20.
53. Sun Y, Fong KY, Chung MC, Yao ZJ. Peptide mimicking antigenic and immunogenic epitope of double-stranded DNA in systemic lupus erythematosus. Int Immunol 2001;13:223-32.
54. Sibille P, Ternynck T, Nato F, Buttin G, Strosberg D, Avrameas A. Mimotopes of polyreactive anti-DNA antibodies identified using phage-display peptide libraries. Eur J Immunol 1997;27:1221-8.